In the latest press release from Bayer MaterialScience about its medically oriented polycarbonate material Makrolon® Rx2530, we’ve stumbled upon this interesting new self-powered pump from German firm RoweMed AG. According to Bayer, its material “provides the high level of transparency, impact strength, resistance to medication, and good sterilization properties required for the RoweMed portable minipump.”
Here’s what we know about the pump, taken from its product brochure:
The RowePump P, a patent pending self-powered elastomeric injection pump, is a new advance in drug delivery technology. RowePump P is a completely new innovation in critical drug administration for preventing allergic reactions and anaphylaxis. RowePump P is the first injection pump worldwide which combines performance, safety, comfort and patient flexibility without any additional electricity and extra equipment. It is ideally designed for improving patients’ quality of life through ambulatory treatment. The system can be refilled several times within 24 hours and is thought to be used for intravenous injection or subcutaneous injection. The pump is available in two sizes, 25 ml and 50 ml maximal filling volume, followed by 10 ml, 100 ml, 150 ml and 250 ml later on. Indeed it may be used for smaller drug volumes. Depending on application area you can choose variable flow rates from 0.5 ml/h up to 25ml/h. The unprecedented constancy of flow rate with deviations of maximal ±5% during whole injection time is the main advantages to be mentioned. The actual flow rate may change within from the nominal rate according to the solution viscosity, the drug concentration and operating temperature. The RowePump P unique “mouse” like design, small profile and lightweight produces the most comfortable disposable pump available today without compromising reservoir volume. The remaining rest volume less than 10% loss of expensive drug makes out a positive effect on today’s already cupped health care systems. It can be used in a wide range of therapies e.g. oncology, chemotherapy, pain treatment, antibiotics, corticoids, hormones, antiepileptica, spasmolytics, cardiology etc. You may be sure that your decision to set the RowePump P for critical drug delivery in sense of patient welfare is a reasonable priced and wise decision.
Product page: RowePump P Portable Minipump…
Read more: Datasheet on Makrolon Rx1805…
Press release: Makrolon® from Bayer MaterialScience in medical applications…